Equity benchmarks nosedived 2 percent on March 16, extending a sharp downtrend for the third consecutive session as the Strait of Hormuz crisis pushed oil prices higher. Market breadth remained weak, with about 2,551 shares declining against 420 advancing shares on the NSE. The market may continue to consolidate with a negative bias amid the West Asia tensions. Below are some short-term trading id...

The benchmark indices remained under pressure for another session, falling nearly 1 percent on March 12 following a rise in oil prices amid Strait of Hormuz tensions. The market breadth was favourable for bears as about 1,920 shares declined against 1,034 rising shares on the NSE. The market is expected to continue to face risk-off sentiment amid geopolitical tensions. Below are some short-term tr...

The benchmark indices corrected sharply after six consecutive days of gains, falling by 1 percent on June 12 due to profit booking. Market breadth was dominated by bears, with 1,945 shares declining versus 660 advancing shares on the NSE. The market may attempt a rebound amid likely range-bound trading in the upcoming session, but the sustainability is the key watch. Below are some short-term trad...

Ajanta Pharma in a communication to stock exchanges informed that its board will meet next week on Tuesday, 10th May, 2022 to consider financial results of the company and issue of bonus shares subject to approval by the shareholders of the company. Bonus shares are fully paid additional shares issued by a company to its existing shareholders."we hereby inform that a meeting of the board of direct...